Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

Clinical trial NCT01152567 · COMPLETED

Trial details

NCT number: NCT01152567
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension Cardiovascular Disease

Start date: 2010-06-01
Primary completion: 2010-11-01
Enrollment: 50000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.